Status:

TERMINATED

Clinical Trial : TROCC (Quick Oral Treatment of Cluster Epileptic Seizures)

Lead Sponsor:

University Hospital, Grenoble

Collaborating Sponsors:

Institut National de la Santé Et de la Recherche Médicale, France

UCB Pharma

Conditions:

Epilepsy

Drug Resistant

Eligibility:

All Genders

18-65 years

Phase:

PHASE3

Brief Summary

This is a double blind, placebo controlled, add-on clinical trial, of levetiracetam efficacy and safety, in epilepsy cluster seizure. Efficacy is evaluated in the range of 2 to 24 hours after taking ...

Detailed Description

Seizure clustering has been defined as a series of unusual frequency of seizures with return to baseline between events. The most common definition of cluster seizure is three seizures per 24 hours. ...

Eligibility Criteria

Inclusion

  • Age from 18 to 65
  • Drug resistant epilepsy, partial seizure
  • Epilepsy diagnosed for more than 2 years
  • Epilepsy treated for more than 1 year with no change of treatment in the month before the enrolment
  • Onset of cluster seizure in the 24 hours before enrolment
  • For women : effective contraception
  • Affiliation to the French social security

Exclusion

  • Inability to tolerate levetiracetam, likely poor compliance
  • Patient taking antiepileptic treatment (benzodiazepine) in addition to current treatment during the last 48h00.
  • Patient taking 1g/day of levetiracetam with Creatinin clearance \< 50ml/min
  • Patient taking 2g/day of levetiracetam with Creatinin clearance \< 80ml/min
  • Patient taking more than 2g/day of levetiracetam
  • Hepatic or cardiovascular pathology
  • Progressive psychiatric pathology
  • Degenerative neurologic disease
  • Cluster seizure due to an acute symptomatic reason
  • Disorder of consciousness
  • Suspicion of status epilepticus or rapid evolution to status epilepticus
  • Suspicion of psychogenic nonepileptic seizure
  • Pregnant woman or nursing woman
  • Suicidal thoughts
  • Incapacity to give consent, minor patient

Key Trial Info

Start Date :

February 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2008

Estimated Enrollment :

112 Patients enrolled

Trial Details

Trial ID

NCT00376766

Start Date

February 1 2007

End Date

April 1 2008

Last Update

May 28 2015

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

Neurology department

Nice, Alpes de Haute provence, France, 06002

2

Etablissement la Teppe

Tain-l'Hermitage, Drome, France, 26600

3

Neurology department

Grenoble, Isere, France, 3043

4

Neurology department

Lille, Nord, France, 59037

Clinical Trial : TROCC (Quick Oral Treatment of Cluster Epileptic Seizures) | DecenTrialz